Granulocyte Transfusions: A Critical Reappraisal

Caterina Giovanna Valentini, Francesca Farina, Livio Pagano, Luciana Teofili*

*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivistaArticolo in rivista

12 Citazioni (Scopus)


Granulocyte transfusions (GTs) are seldom used as a life-saving therapy for neutropenic patients with severe infections. Despite compelling evidence of GT efficacy in retrospective and prospective case series, no study has been successful in demonstrating a definite advantage for recipients in controlled clinical trials. This review critically revises some aspects emerging from past experience that might have weakened the evidence of GT benefits. Some specific issues relevant to the efficacy of this therapeutic approach, such as primary infection, delivered doses and schedules, and immunologic effects of GTs, are discussed. Importantly, the awareness of biologic effects accompanying the transfusion of neutrophils might support their use at standardized doses and may definitely convey significant advantages to the recipient patients.
Lingua originaleEnglish
pagine (da-a)2034-2041
Numero di pagine8
RivistaBiology of Blood and Marrow Transplantation
Stato di pubblicazionePubblicato - 2017


  • Granulocytes
  • Hematology
  • Individualized medicine
  • Infections
  • Personalized therapies
  • Transplantation


Entra nei temi di ricerca di 'Granulocyte Transfusions: A Critical Reappraisal'. Insieme formano una fingerprint unica.

Cita questo